1. Home
  2. LIXT vs WORX Comparison

LIXT vs WORX Comparison

Compare LIXT & WORX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • WORX
  • Stock Information
  • Founded
  • LIXT 2005
  • WORX N/A
  • Country
  • LIXT United States
  • WORX United States
  • Employees
  • LIXT N/A
  • WORX N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • WORX Services-Misc. Amusement & Recreation
  • Sector
  • LIXT Health Care
  • WORX Consumer Discretionary
  • Exchange
  • LIXT Nasdaq
  • WORX Nasdaq
  • Market Cap
  • LIXT 4.1M
  • WORX 3.4M
  • IPO Year
  • LIXT N/A
  • WORX N/A
  • Fundamental
  • Price
  • LIXT $1.93
  • WORX $1.51
  • Analyst Decision
  • LIXT
  • WORX
  • Analyst Count
  • LIXT 0
  • WORX 0
  • Target Price
  • LIXT N/A
  • WORX N/A
  • AVG Volume (30 Days)
  • LIXT 19.4K
  • WORX 7.8M
  • Earning Date
  • LIXT 11-12-2024
  • WORX 11-14-2024
  • Dividend Yield
  • LIXT N/A
  • WORX N/A
  • EPS Growth
  • LIXT N/A
  • WORX N/A
  • EPS
  • LIXT N/A
  • WORX N/A
  • Revenue
  • LIXT N/A
  • WORX $3,224,146.00
  • Revenue This Year
  • LIXT N/A
  • WORX N/A
  • Revenue Next Year
  • LIXT N/A
  • WORX N/A
  • P/E Ratio
  • LIXT N/A
  • WORX N/A
  • Revenue Growth
  • LIXT N/A
  • WORX N/A
  • 52 Week Low
  • LIXT $1.31
  • WORX $0.75
  • 52 Week High
  • LIXT $4.40
  • WORX $4.44
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 57.92
  • WORX 47.01
  • Support Level
  • LIXT $1.85
  • WORX $1.43
  • Resistance Level
  • LIXT $2.65
  • WORX $2.16
  • Average True Range (ATR)
  • LIXT 0.18
  • WORX 0.19
  • MACD
  • LIXT 0.03
  • WORX -0.09
  • Stochastic Oscillator
  • LIXT 43.37
  • WORX 12.18

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About WORX SCWorx Corp.

SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.

Share on Social Networks: